Flagship Pioneering Inc.

CIK 000140024013 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001400240

Recent Transactions

50 trades

Award
Foghorn Therapeutics Inc.$FHTX
Series 1 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total
Award
Foghorn Therapeutics Inc.$FHTX
Series 2 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total
Award
Foghorn Therapeutics Inc.$FHTX
Pre-Funded Warrants to purchase Common Stock
2026-01-13$6.71/sh+2,235,468→ 2,235,468 total
Purchase
Foghorn Therapeutics Inc.$FHTX
Pre-Funded Warrants to purchase Common Stock
2024-05-22$5.51/sh+1,814,915→ 1,814,915 total
Purchase
Foghorn Therapeutics Inc.$FHTX
Pre-Funded Warrants to purchase Common Stock
2024-05-22$5.51/sh+1,814,914→ 1,814,914 total
Purchase
Sana Biotechnology, Inc.$SANA
Pre-Funded Warrants to purchase Common Stock
2024-02-12$5.50/sh+2,727,272→ 2,727,272 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−70,813→ 0 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−345,069→ 1,035,208 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−4,926,378→ 8,057,470 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−2,431,281→ 7,293,841 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−1,181,745→ 0 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−2,825,989→ 8,615,337 total
Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−683,760→ 0 total
Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−113,960→ 0 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2023-07-11$2.31/sh+1,082,251→ 1,461,795 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2023-07-11$2.31/sh+3,246,753→ 3,931,685 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2023-07-11$2.31/sh+1,082,251→ 1,493,241 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2023-02-27$5.78/sh+1,329,324→ 1,329,324 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2023-02-27$5.78/sh+1,993,986→ 7,508,693 total
Purchase
Seres Therapeutics, Inc.$MCRB
Common Stock
2022-07-05$3.15/sh+2,912,748→ 5,875,711 total
Purchase
Seres Therapeutics, Inc.$MCRB
Common Stock
2022-07-05$3.15/sh+5,825,495→ 5,825,495 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2022-05-27$1.46/sh+6,849,315→ 8,219,791 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2022-05-27$1.46/sh+13,698,630→ 13,698,630 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2022-05-27$1.46/sh+4,383,561→ 7,590,873 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2022-05-27$1.46/sh+1,369,863→ 5,495,324 total
Purchase
Evelo Biosciences, Inc.
Common Stock
2022-05-27$1.46/sh+1,095,890→ 1,887,419 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−1,666,666→ 0 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+970,588→ 970,588 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,088,470→ 1,088,470 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−3,000,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−27,388,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−22,275,232→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−2,666,667→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−13,333,333→ 0 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+8,396,825→ 8,396,825 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+294,117→ 1,617,646 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+220,588→ 8,617,413 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−3,333,333→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−22,275,232→ 0 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+5,896,386→ 5,896,386 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−4,112,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−4,112,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−13,333,333→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+661,764→ 5,514,707 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+970,588→ 970,588 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+4,852,943→ 4,852,943 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,323,529→ 1,323,529 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−666,667→ 0 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−5,000,000→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+220,588→ 8,617,413 total

Flagship Pioneering Inc.

Recent Transactions

Companies

Recent Filings

Address